Abstract
According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.
| Original language | English (US) |
|---|---|
| Title of host publication | Handbook of Lasers in Dermatology |
| Publisher | Springer London |
| Pages | 293-306 |
| Number of pages | 14 |
| ISBN (Electronic) | 9781447153221 |
| ISBN (Print) | 9781447153214 |
| DOIs | |
| State | Published - Jan 1 2014 |
Fingerprint
Keywords
- Basal cell carcinoma
- Dermatology
- Laser
- Non-melanoma skin cancer
- Skin cancer
- Squamous cell carcinoma
- Treatment
ASJC Scopus subject areas
- Medicine(all)
Cite this
Lasers for non-melanoma skin cancers. / Savas, Jessica A.; Ledon, Jennifer A.; França, Kaitlein; Chacon, Anna H.; Nouri, Keyvan.
Handbook of Lasers in Dermatology. Springer London, 2014. p. 293-306.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Lasers for non-melanoma skin cancers
AU - Savas, Jessica A.
AU - Ledon, Jennifer A.
AU - França, Kaitlein
AU - Chacon, Anna H.
AU - Nouri, Keyvan
PY - 2014/1/1
Y1 - 2014/1/1
N2 - According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.
AB - According to the most recent incidence data, approximately 3.5 million cases of non-melanoma skin cancer (NMSC) are diagnosed each year, affecting 2.1 million people in the United States alone (Rogers et al., Arch Dermatol 146:283-287, 2010). Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS) represent the overwhelming majority of NMSCs, with BCC and its subtypes being the most common malignancy affecting Caucasians (Rogers et al., Arch Dermatol 146:283-287, 2010). Traditional treatments of NMSCs include standard excision, Mohs micrographic surgery, curettage and electrodessication (C&E), cryotherapy, radiotherapy, and topical cytotoxic therapy (e.g. fluorouracil). Some patients, especially those with multiple lesions, may not be amenable to several destructive or surgical interventions due to multiple comorbidities or fear of disfigurement, while others may be unable to tolerate the inflammatory side effects of topical preparations. A less invasive modality with fewer adverse effects and comparable efficacy is needed in certain patient populations, and to this end, lasers have shown great promise in carefully selected patients. This chapter will address the indications, procedural techniques, pre-operative and postoperative considerations as well as the prevention and management of complications when using lasers for the treatment of skin cancer.
KW - Basal cell carcinoma
KW - Dermatology
KW - Laser
KW - Non-melanoma skin cancer
KW - Skin cancer
KW - Squamous cell carcinoma
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85028390583&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028390583&partnerID=8YFLogxK
U2 - 10.1007/978-1-4471-5322-1_19
DO - 10.1007/978-1-4471-5322-1_19
M3 - Chapter
SN - 9781447153214
SP - 293
EP - 306
BT - Handbook of Lasers in Dermatology
PB - Springer London
ER -